logo-loader

Riccardo Lowi discusses Avacta

Published: 06:44 04 May 2018 EDT

Riccardo lowi discusses Avacta's good progress on both the Affimer therapeutics and reagents programs.

Novo Resources sees substantial upside potential at Nunyerry

Novo Resources Corp (TSX:NVO, OTCQX:NSRPF, ASX:NVO) co-chair and acting CEO Mike Spreadborough joins Jonathan Jackson in the Proactive studio to discuss promising gold outcomes from recent reanalysis of drill intercepts in a 2023 program at Nunyerry North in Western Australia. Using advanced...

9 hours ago